NLRP3 and autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation: Collectively, these results suggest an over-activation of the alternative NLRP3 inflammasome pathway in monocytes from APLAID patients, which could be enhanced by the elevated levels of intracellular calcium associated with the increased activity of mutated PLCγ2.